It has been reported that SIRT2 plays critical roles in non-small cell lung cancer growth and metastasis through inducing p53 acetylation and reducing the transcriptional activity of p53 (Wang et al., 2019). This evidence concerns the gene TP53 and non-small cell lung carcinoma.